Neuropathological alterations in Alzheimer disease

Serrano-Pozo, A., Frosch, M. P., Masliah, E., Hyman, B. T.·2011·Cold Spring Harbor Perspectives in Medicine

Cited by (1,028)

Items 1,001–1,028 of 1,028

  1. Cell death and survival pathways in Alzheimer's disease: an integrative hypothesis testing approach utilizing -omic data sets
    Danielle L. Brokaw, Ignazio Stefano Piras, Diego Mastroeni, Daniel J. Weisenberger, Jennifer Nolz, Elaine Delvaux, Geidy E. Serrano, Thomas G. Beach, Matthew J. Huentelman, Paul D. Coleman · 2020 · Neurobiology of Aging
  2. The Dichotomous Role of Extracellular Vesicles in the Central Nervous System
    Graykowski, David R., Wang, Yi-Zhi, Upadhyay, Arun, Savas, Jeffrey N. · 2020 · iScience
  3. Comparative Efficacy and Safety of Monoclonal Antibodies for Cognitive Decline in Patients with Alzheimer’s Disease: A Systematic Review and Network Meta-Analysis
    Qiao, Yue, Gu, Jian, Yu, Miao, Chi, Yuewei, Ma, Ying · 2024 · CNS Drugs
  4. A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte
    Wang, Xueying, Yang, Huihui, Liu, Chunyu, Liu, Kefu · 2023 · Frontiers in Molecular Neuroscience
  5. Microglial cGAS Deletion Preserves Intercellular Communication and Alleviates Amyloid‐β‐Induced Pathogenesis of Alzheimer's Disease
    He, Sijia, Li, Xin, Mittra, Namrata, Bhattacharjee, Anindita, Wang, Hu, Song, Shujie, Zhao, Shangang, Liu, Feng, Han, Xianlin · 2025 · Advanced Science
  6. Progress and challenges in the diagnosis of dementia: a critical review
    Paraskevaidi, Maria, Martin-Hirsch, Pierre L., Martin, Francis L. · 2018 · ACS Chemical Neuroscience
  7. Steroid-ENRICHED FRAction of Achyranthes bidentata protects Amyloid β peptide 1–40-induced cognitive dysfunction and neuroinflammation in rats
    Lin, Li-Wei, Tsai, Fan-Hsuan, Lan, Wan-Cheng, Cheng, Yih-Dih, Lee, Sheng-Chi, Wu, Chi-Rei · 2019 · Molecular Neurobiology
  8. Neuroimaging of mouse models of Alzheimer’s disease
    Jullienne, Amandine, Trinh, Michelle V., Obenaus, Andre · 2022 · Biomedicines
  9. <p>Long-term icariin treatment ameliorates cognitive deficits via CD4<sup>+</sup> T cell-mediated immuno-inflammatory responses in APP/PS1 mice</p>
    Zhu, Tianrui, Zhang, Feng, Li, Heng, He, Yi, Zhang, Guitao, Huang, Nana, Guo, Mingming, Li, Xiaohong · 2019 · Clinical Interventions in Aging
  10. THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency
    Vautheny, Audrey, Duwat, Charlotte, Aurégan, Gwennaëlle, Joséphine, Charlène, Hérard, Anne-Sophie, Jan, Caroline, Mitja, Julien, Gipchtein, Pauline, Gaillard, Marie-Claude, Buée, Luc et al. · 2021 · Neurobiology of Disease
  11. Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of Aβ amyloidosis
    Kim, Byungwook, Dabin, Luke Child, Tate, Mason Douglas, Karahan, Hande, Sharify, Ahmad Daniel, Acri, Dominic J., Al-Amin, Md Mamun, Philtjens, Stéphanie, Smith, Daniel Curtis, Wijeratne, H. R. Sagara et al. · 2024 · Nature Communications
  12. Versatile nanomaterials for Alzheimer’s disease: Pathogenesis inspired disease-modifying therapy
    Xi, Yilong, Chen, Yun, Jin, Yi, Han, Guochen, Song, Mingjie, Song, Tingting, Shi, Yang, Tao, Ling, Huang, Zewei, Zhou, Jianping et al. · 2022 · Journal of Controlled Release
  13. Biomarker-based signature of alzheimer's disease in pre-MCI individuals
    Chipi, Elena, Salvadori, Nicola, Farotti, Lucia, Parnetti, Lucilla · 2019 · Brain Sciences
  14. Deep Profiling of the Aggregated Proteome in Alzheimer’s Disease: From Pathology to Disease Mechanisms
    Lutz, Brianna M., Peng, Junmin · 2018 · Proteomes
  15. Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: Novel hints on immunosenescence and biomarker detection
    Tramutola, Antonella, Abate, Giulia, Lanzillotta, Chiara, Triani, Francesca, Barone, Eugenio, Iavarone, Federica, Vincenzoni, Federica, Castagnola, Massimo, Marziano, Mariagrazia, Memo, Maurizio et al. · 2018 · Free Radical Biology and Medicine
  16. Altered Metabolism and DAM-signatures in Female Brains and Microglia with Aging
    Cleland, Nicholas R.W., Potter, Garrett J., Buck, Courtney, Quang, Daphne, Oldham, Dean, Neal, Mikaela, Saviola, Anthony, Niemeyer, Christy S., Dobrinskikh, Evgenia, Bruce, Kimberley D. · 2024 · Brain Research
  17. Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease—From Brain Starch to Bench and Bedside
    Pawlowski, Matthias, Meuth, Sven, Duning, Thomas · 2017 · Diagnostics
  18. 3D bioengineered neural tissue generated from patient-derived iPSCs mimics time-dependent phenotypes and transcriptional features of Alzheimer’s disease
    Lomoio, Selene, Pandey, Ravi S., Rouleau, Nicolas, Menicacci, Beatrice, Kim, WonHee, Cantley, William L., Haydon, Philip G., Bennett, David A., Young-Pearse, Tracy L., Carter, Gregory W. et al. · 2023 · Molecular Psychiatry
  19. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons
    Oakley, Derek H., Klickstein, Naomi, Commins, Caitlin, Chung, Mirra, Dujardin, Simon, Bennett, Rachel E., Hyman, Bradley T., Frosch, Matthew P. · 2021 · The Journal of Neuroscience
  20. Antioxidant and Cholinesterase Inhibitory Activities of Ethyl Acetate Extract of Terminalia chebula: Cell-Free in Vitro and in Silico Studies
    Natarajan, Suganthy, Govindaraju, Archunan, Rajmohamed, MohamedAsik, Palanisamy, Premkumar, Abdulkader, AkbarshaMohammad · 2017 · Pharmacognosy Magazine
  21. Crude Saponin from Platycodon grandiflorum Attenuates Aβ-Induced Neurotoxicity via Antioxidant, Anti-Inflammatory and Anti-Apoptotic Signaling Pathways
    Ji, Yun-Jeong, Kim, Sujin, Kim, Jwa-Jin, Jang, Gwi Yeong, Moon, Minho, Kim, Hyung Don · 2021 · Antioxidants
  22. Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases
    Ferrantelli, Flavia, Chiozzini, Chiara, Leone, Patrizia, Manfredi, Francesco, Federico, Maurizio · 2020 · Pharmaceutics
  23. β-amyloid accumulation enhances microtubule associated protein tau pathology in an APPNL-G-F/MAPTP301S mouse model of Alzheimer’s disease
    Jiang, Lulu, Roberts, Rebecca, Wong, Melissa, Zhang, Lushuang, Webber, Chelsea Joy, Libera, Jenna, Wang, Zihan, Kilci, Alper, Jenkins, Matthew, Ortiz, Alejandro Rondón et al. · 2024 · Frontiers in Neuroscience
  24. Cyclopamine Modulates γ-Secretase-mediated Cleavage of Amyloid Precursor Protein by Altering Its Subcellular Trafficking and Lysosomal Degradation
    Vorobyeva, Anna G., Lee, Randall, Miller, Sean, Longen, Charles, Sharoni, Michal, Kandelwal, Preeti J., Kim, Felix J., Marenda, Daniel R., Saunders, Aleister J. · 2014 · Journal of Biological Chemistry
  25. Metabolites Associated with Early Cognitive Changes Implicated in Alzheimer’s Disease
    Darst, Burcu F., Huo, Zhiguang, Jonaitis, Erin M., Koscik, Rebecca L., Clark, Lindsay R., Lu, Qiongshi, Kremen, William S., Franz, Carol E., Rana, Brinda, Lyons, Michael J. et al. · 2021 · Journal of Alzheimer’s Disease
  26. Cytoplasmic Mislocalization of RNA Polymerase II Subunit RPB1 in Alzheimer Disease Is Linked to Pathologic Tau
    Dickson, John R, Yoon, Hyejin, Frosch, Matthew P, Hyman, Bradley T · 2021 · Journal of Neuropathology & Experimental Neurology
  27. Distinct microglia profile in Creutzfeldt-Jakob disease and Alzheimer’s disease is independent of disease kinetics
    Krbot, Katarina, Hermann, Peter, Skorić, Magdalena Krbot, Zerr, Inga, Sepulveda‐Falla, Diego, Goebel, Stefan, Matschke, Jakob, Krasemann, Susanne, Glatzel, Markus · 2018 · Neuropathology
  28. Targeting Microglial Transcriptional Reprogramming as a Therapy Strategy for Alzheimer's Disease
    Kim, Byungwook, Wang, Selena S., Kim, Justin R., Kim, Jungsu · 2026 · BioEssays